Have you been diagnosed with Atrial Fibrillation (AFib)?

Trial Information:

The LIBREXIA 3002 study by Janssen will compare the effects of an experimental drug, milvexia, to the comparator drug, apixaban, to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain (non-central nervous system (CNS) systemic embolism) in participants with atrial fibrillation.

Dr. Geeta Reddy is the leading physician (called the "principal investigator") for this trial at our affiliate clinic in Libertyville, IL. We are currently accepting new patients for this study.

For more information on this clinical trial, please call us at 847-691-3856 and ask to speak to our recruiter Maria.

Study Protocol: JNJ-70033093AFL3002